A carregar...
Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
AIMS: Despite well‐established benefits of sacubitril/valsartan for cardiac reverse remodelling and the prognosis of patients with heart failure with reduced ejection fraction (HFrEF), there are some patients with limited therapeutic response, even with optimal therapy. We assessed the treatment res...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120366/ https://ncbi.nlm.nih.gov/pubmed/33682334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13285 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|